Prescription Gastrointestinal Drugs Market Report

Europe Prescription Gastrointestinal Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 29, 2020
  • PAGES：209
  • REPORT CODE：GMM488969
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Prescription Gastrointestinal Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Prescription Gastrointestinal Drugs Market Segmentations:

    By Player:

    • AstraZeneca

    • Salix Pharmaceuticals

    • GlaxoSmithKline

    • Axcan Pharmaceuticals

    • Merck

    • Eisai

    By Type:

    • Oral

    • Topical

    By End-User:

    • Hospital Pharmacies

    • Online Pharmacies

    • Retail Pharmacies

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prescription Gastrointestinal Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Oral from 2014 to 2026

    • 1.3.2 Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Topical from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • 1.4.2 Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.4.3 Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Prescription Gastrointestinal Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prescription Gastrointestinal Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Oral

      • 3.4.2 Market Size and Growth Rate of Topical

    4 Segmentation of Prescription Gastrointestinal Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prescription Gastrointestinal Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Prescription Gastrointestinal Drugs for Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Prescription Gastrointestinal Drugs for Online Pharmacies

      • 4.4.3 Market Size and Growth Rate of Prescription Gastrointestinal Drugs for Retail Pharmacies

    5 Market Analysis by Major Regions

    • 5.1 Europe Prescription Gastrointestinal Drugs Production Analysis by Top Regions

    • 5.2 Europe Prescription Gastrointestinal Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Prescription Gastrointestinal Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Prescription Gastrointestinal Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Prescription Gastrointestinal Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Prescription Gastrointestinal Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Prescription Gastrointestinal Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Prescription Gastrointestinal Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Prescription Gastrointestinal Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Prescription Gastrointestinal Drugs Landscape Analysis

    • 7.1 Germany Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 7.2 Germany Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    8. UK Prescription Gastrointestinal Drugs Landscape Analysis

    • 8.1 UK Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 8.2 UK Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    9. France Prescription Gastrointestinal Drugs Landscape Analysis

    • 9.1 France Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 9.2 France Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    10. Italy Prescription Gastrointestinal Drugs Landscape Analysis

    • 10.1 Italy Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 10.2 Italy Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    11. Spain Prescription Gastrointestinal Drugs Landscape Analysis

    • 11.1 Spain Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 11.2 Spain Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    12. Poland Prescription Gastrointestinal Drugs Landscape Analysis

    • 12.1 Poland Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 12.2 Poland Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    13. Russia Prescription Gastrointestinal Drugs Landscape Analysis

    • 13.1 Russia Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 13.2 Russia Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    14. Switzerland Prescription Gastrointestinal Drugs Landscape Analysis

    • 14.1 Switzerland Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    15. Turkey Prescription Gastrointestinal Drugs Landscape Analysis

    • 15.1 Turkey Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Prescription Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Prescription Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Prescription Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Prescription Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Prescription Gastrointestinal Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Prescription Gastrointestinal Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Prescription Gastrointestinal Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Prescription Gastrointestinal Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Prescription Gastrointestinal Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Prescription Gastrointestinal Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Prescription Gastrointestinal Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 AstraZeneca

      • 19.1.1 AstraZeneca Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Salix Pharmaceuticals

      • 19.2.1 Salix Pharmaceuticals Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GlaxoSmithKline

      • 19.3.1 GlaxoSmithKline Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Axcan Pharmaceuticals

      • 19.4.1 Axcan Pharmaceuticals Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Merck

      • 19.5.1 Merck Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Eisai

      • 19.6.1 Eisai Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    The List of Tables and Figures (Totals 67 Figures and 130 Tables)

    • Figure Product Picture

    • Figure Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Oral from 2014 to 2026

    • Figure Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Topical from 2014 to 2026

    • Figure Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Europe Prescription Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Germany Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Prescription Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prescription Gastrointestinal Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prescription Gastrointestinal Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prescription Gastrointestinal Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Prescription Gastrointestinal Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Topical

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prescription Gastrointestinal Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prescription Gastrointestinal Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Table Europe Prescription Gastrointestinal Drugs Production by Major Regions

    • Table Europe Prescription Gastrointestinal Drugs Production Share by Major Regions

    • Figure Europe Prescription Gastrointestinal Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Prescription Gastrointestinal Drugs Consumption by Major Regions

    • Table Europe Prescription Gastrointestinal Drugs Consumption Share by Major Regions

    • Table Germany Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table UK Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table France Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Prescription Gastrointestinal Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Prescription Gastrointestinal Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Prescription Gastrointestinal Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Prescription Gastrointestinal Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Germany Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table UK Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table France Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table France Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table France Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Italy Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Spain Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Poland Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Russia Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prescription Gastrointestinal Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prescription Gastrointestinal Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prescription Gastrointestinal Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Prescription Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Salix Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals

    • Table Product and Service Introduction of Salix Pharmaceuticals

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Axcan Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Axcan Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Axcan Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Axcan Pharmaceuticals

    • Table Product and Service Introduction of Axcan Pharmaceuticals

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US